biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

RAPORT KWARTALNY 3/2020 | 14-02-2020 | Jednostkowy i skonsolidowany raport okresowy za IV kwartał 2019 roku

Previous PostNext Post

Related Posts

18.11.2024

Scope Fluidics Secures $30 Million from Conditional Payment Settlement with Bio-Rad Laboratories in Curiosity Diagnostics Sale

0
24.09.2024

Scope Fluidics Signs Agreement for IVDR Certification of Innovative BACTEROMIC System

0
04.09.2024

Notified Body Initiates IVDR Certification Readiness Assessment for BACTEROMIC System, Developed by Scope Fluidics Group

0